Scholarlink

Background <p>Insulin resistance (IR) is a central pathological feature of childhood obesity. Spexin (SPX), an emerging endogenous metabolic regulatory peptide, plays a key role in regulating energy metabolism. This study aimed to evaluate the association between IR and serum levels of SPX and adiponectin (ADP) and assess their biomarker potential for predicting IR in children with obesity.</p> Methods <p>In total, the study enrolled 104 children (40 normal weight and 64 obese) aged 7–18 years. Further, children with obesity were categorized as having IR (<i>n</i> = 37) or not (<i>n</i> = 27) using a homeostatic model assessment of IR (HOMA-IR) cutoff of ≥ 3.0. Anthropometric measurements; biochemical profiles (including glucose, lipid, and liver enzyme levels); and serum concentrations of SPX, Gremlin-1, ADP, leptin (LEP), and tumor necrosis factor-alpha (TNF-α) were evaluated. The statistical analyses included correlation tests, multiple linear regression to identify independent determinants of HOMA-IR, and receiver operating characteristic (ROC) curve analysis to assess diagnostic performance.</p> Results <p>Children with obesity and IR exhibited significantly lower serum SPX levels compared with those without IR, indicating a biphasic pattern characterized by a “compensatory increase” followed by a “decompensated decrease.” Multiple linear regressions identified triglycerides (β = 0.211, <i>p</i> = 0.021), SPX (β = −0.398, <i>p</i> = 0.049), and ADP (β = −0.577, <i>p</i> = 0.005) as independent factors associated with HOMA-IR. ROC curve analysis revealed that ADP (area under the curve [AUC] = 0.634) and SPX (AUC = 0.602) had significant, albeit modest, diagnostic value for predicting IR, outperforming Gremlin-1, LEP, and TNF-α.</p> Conclusions <p>Serum SPX and ADP levels are significantly associated with IR in children with obesity and show potential as complementary early biomarkers. The biphasic change in SPX, characterized by an initial compensatory rise followed by a decompensatory decline, suggests a complex role in metabolic adaptation and failure, underscoring its pathophysiological relevance in the progression from obesity to IR. Thus, a screening approach that combines SPX and ADP may improve early identification of children at risk of obesity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Circulating spexin and adiponectin as early biomarkers of insulin resistance in pediatric obesity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月10日

查看全文
  • Biyao Lian,
  • Yi Ding,
  • Hongai Zhang,
  • Yuesheng Liu,
  • Yanfeng Xiao,
  • Chunyan Yin

摘要

Background

Insulin resistance (IR) is a central pathological feature of childhood obesity. Spexin (SPX), an emerging endogenous metabolic regulatory peptide, plays a key role in regulating energy metabolism. This study aimed to evaluate the association between IR and serum levels of SPX and adiponectin (ADP) and assess their biomarker potential for predicting IR in children with obesity.

Methods

In total, the study enrolled 104 children (40 normal weight and 64 obese) aged 7–18 years. Further, children with obesity were categorized as having IR (n = 37) or not (n = 27) using a homeostatic model assessment of IR (HOMA-IR) cutoff of ≥ 3.0. Anthropometric measurements; biochemical profiles (including glucose, lipid, and liver enzyme levels); and serum concentrations of SPX, Gremlin-1, ADP, leptin (LEP), and tumor necrosis factor-alpha (TNF-α) were evaluated. The statistical analyses included correlation tests, multiple linear regression to identify independent determinants of HOMA-IR, and receiver operating characteristic (ROC) curve analysis to assess diagnostic performance.

Results

Children with obesity and IR exhibited significantly lower serum SPX levels compared with those without IR, indicating a biphasic pattern characterized by a “compensatory increase” followed by a “decompensated decrease.” Multiple linear regressions identified triglycerides (β = 0.211, p = 0.021), SPX (β = −0.398, p = 0.049), and ADP (β = −0.577, p = 0.005) as independent factors associated with HOMA-IR. ROC curve analysis revealed that ADP (area under the curve [AUC] = 0.634) and SPX (AUC = 0.602) had significant, albeit modest, diagnostic value for predicting IR, outperforming Gremlin-1, LEP, and TNF-α.

Conclusions

Serum SPX and ADP levels are significantly associated with IR in children with obesity and show potential as complementary early biomarkers. The biphasic change in SPX, characterized by an initial compensatory rise followed by a decompensatory decline, suggests a complex role in metabolic adaptation and failure, underscoring its pathophysiological relevance in the progression from obesity to IR. Thus, a screening approach that combines SPX and ADP may improve early identification of children at risk of obesity.